Atea Pharmaceuticals, Inc. — Form D
Atea Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-16. The offering totals $27.6M, of which $27.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-07-16
- Form: D
- Accession: 0001140361-18-032512
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $27.6M
- Amount sold: $27.6M
- Investors: 38
- Date of first sale: 2018-06-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-316941
Issuer
- Name: Atea Pharmaceuticals, Inc.
- CIK: 0001593899
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 125 SUMMER ST., BOSTON, MA, 02110
- Phone: 857-204-8109
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Gerald Chan | Director | Monaco, O9 |
| Jean-Pierre Sommadossi | Director | Boston, MA |
| Fan Yu | Director | Grand Cayman, E9 |
| Evgeny Zatsev | Director | Boston, MA |
| Jean-Pierre Sommadossi | Executive Officer | Boston, MA |
| BIHUA CHEN | Director | Boston, MA |
| Frank Yu | Director | Campbell, CA |
| Grigory Borisenko | Director | SAN DIEGO, CA |
| Franklin Berger | Director | Newark, CA |
| Jean-Pierre Sommadossi, Ph.D. | Director | Boston, MA |
| Jean-Pierre Sommadossi, Ph.D. | Executive Officer | Boston, MA |
| Andrew Hack, M.D., Ph.D. | Director | Boston, MA |
| Bruno Lucidi | Director | Boston, MA |
| Bruce Polsky | Director | Boston, MA |
| Andrea Corcoran | Executive Officer | Boston, MA |
| Isaac Cheng, M.D. | Director | Boston, MA |
Other filings by this issuer (5)
More